ALS prevalence is expected to rise by more than 10% by 2030.
More people will need access to promising therapies. That's why ACT for ALS must move forward.
ALS doesn't wait. Neither can we.
Ask your representative to cosponsor ACT for ALS: bit.ly/fundALS
